Literature DB >> 7876658

Visualization of myocardial infarction six hours after injection of 111 In-antimyosin antibodies using an image subtraction technique.

J Ouzan1, D Wilson, C Pèrualt, D Metz, F Torossian, C Gibold, A Loboguerrero, E Carre, J C Liehn, J Elaerts.   

Abstract

111 In-antimyosin antibodies are capable of visualizing acute myocardial infarction (MI). Because of slow blood clearance, images are usually recorded 24 or 48 h postinjection. This pilot study was aimed at validating a blood pool subtraction technique, which makes it possible to visualize MI 6 h postinjection. Twenty-five patients with proven MI (16 anterior, 9 inferior) were imaged 10 minutes, 6 and 24 h after an injection of 110 MBq 111 In-labelled antimyosin antibodies, with a mean delay of two weeks after infarction. Three planar views were obtained each time. Using software which performs geometric registration, grey level normalization and subtraction of images, the blood pool image (obtained 10 minutes postinjection) was subtracted from the 6 hour image. The resulting image was the blood pool corrected 6 h image. The 24 h images and the blood pool corrected 6 h images were interpreted blindly and the number of correct, incorrect and indeterminate MI localizations were tabulated. The number of correct localizations was 19/25 for the standard 24 h images and 22/25 for the blood pool corrected 6 h images. With this blood pool subtraction method it was possible to visualize MI 6 h postinjection. Theoretically, this method could be applied six hours after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7876658     DOI: 10.1007/bf01137900

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  15 in total

Review 1.  Clinical role of indium-111 antimyosin imaging.

Authors:  S Bhattacharya; A Lahiri
Journal:  Eur J Nucl Med       Date:  1991

2.  Automated comparison of scintigraphic images.

Authors:  A Venot; J C Liehn; J F Lebruchec; J C Roucayrol
Journal:  J Nucl Med       Date:  1986-08       Impact factor: 10.057

3.  A new approach to image subtraction in immunoscintigraphy: preliminary results.

Authors:  J C Liehn; P Hannequin; S Nasca; D Lebrun; A Cattan; J Valeyre
Journal:  Eur J Nucl Med       Date:  1987

4.  Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies.

Authors:  B A Khaw; J T Fallon; G A Beller; E Haber
Journal:  Circulation       Date:  1979-12       Impact factor: 29.690

5.  Diagnosis of acute myocardial infarction by indium-111 antimyosin antibodies and correlation with the traditional techniques for the evaluation of extent and localization.

Authors:  M Volpini; R Giubbini; P Gei; C Cuccia; P Franzoni; S Riva; A Terzi; M Metra; M Bestagno; O Visioli
Journal:  Am J Cardiol       Date:  1989-01-01       Impact factor: 2.778

6.  Improvement of parathyroid Tl-Tc scintigraphy by using a new image subtraction method.

Authors:  J C Liehn; S Amico; M J Delisle; J B Flament
Journal:  Eur J Nucl Med       Date:  1988

7.  Dual isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk.

Authors:  L L Johnson; D W Seldin; A M Keller; R M Wall; K Bhatia; C O Bingham; M E Tresgallo
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

8.  What factors determine indium-111 antimyosin monoclonal antibody uptake in patients with myocardial infarction?

Authors:  J Ouzan; D Metz; D Jolly; J C Liehn; J Elaerts
Journal:  Int J Cardiol       Date:  1993-07-15       Impact factor: 4.164

9.  Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres.

Authors:  B A Khaw; J Scott; J T Fallon; S L Cahill; E Haber; C Homcy
Journal:  Science       Date:  1982-09-10       Impact factor: 47.728

10.  Antimyosin imaging in acute transmural myocardial infarctions: results of a multicenter clinical trial.

Authors:  L L Johnson; D W Seldin; L C Becker; N D LaFrance; H A Liberman; C James; J A Mattis; R T Dean; J Brown; A Reiter
Journal:  J Am Coll Cardiol       Date:  1989-01       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.